Matsukiyococokara & Co. (3088) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Matsukiyococokara & Co. (3088:JPX), powered by AI.

Current Price
¥2,337
P/E Ratio
17.5
Market Cap
954.6B
Sector
Healthcare
What is the Matsukiyococokara & Co. stock price forecast?

Matsukiyococokara & Co. is currently trading at ¥2,337. View real-time AI analysis on Alpha Lenz.

What is Matsukiyococokara & Co. insider trading activity?

View the latest insider trading data for Matsukiyococokara & Co. on Alpha Lenz.

What is Matsukiyococokara & Co.'s P/E ratio?

Matsukiyococokara & Co.'s P/E ratio is 17.5.

Matsukiyococokara & Co.

JPX · 3088
¥2,337+3(+0.13%)Market closedJPX regular session 09:00–15:00 JST
Ask about Matsukiyococokara & Co.'s future dividend policy...
Alpha Chat Insight

Matsukiyococokara & Co. trades at a P/E of 17.5 (fair value) with solid ROE of 10.6%. 3Y revenue CAGR of 13.3% highlights clear growth momentum.

Ask for details

Company Overview

Matsukiyococokara & Co. is a prominent entity within the retail sector, operating as a major drugstore chain in Japan. This asset primarily serves the consumer market through its extensive network of stores, providing a wide range of health-related products, cosmetics, daily necessities, and over-the-counter pharmaceuticals. The company aims to meet consumer needs by offering both Japanese and international brands, alongside its private-label products. Matsukiyococokara & Co. has a strong presence in the densely populated urban areas and continues to expand its reach across the country. The company caters to diverse customer demographics, offering accessible and convenient shopping experiences. Its strategic focus includes enhancing digital sales channels and utilizing data-driven approaches to personalize services and improve customer experience. In the financial market, the company is noteworthy for investors and analysts interested in the retail and healthcare sectors, reflecting broader market trends and consumer behaviors. As a player in the competitive Japanese retail landscape, Matsukiyococokara & Co. contributes significantly to the accessibility of health and beauty products, influencing both domestic consumption patterns and the health and wellness industry.

CEOMr. Kiyoo Matsumoto
SectorHealthcare
IndustryPharmaceutical Retailers
Employees12,753

Company Statistics

FY 2025

Profile

¥954,616,921,017Market Cap
¥1,061,626,000,000Revenue
0.00Shares Out
12,753Employees

Margins

35.06%Gross
10.28%EBITDA
7.73%Operating
7.90%Pre-Tax
5.18%Net

Valuation

17.46P/E
1.83P/B
0.90EV/Sales
7.75EV/EBITDA
14.24P/FCF

Growth (CAGR)

13.30%Rev 3Yr
12.44%Rev 5Yr
25.94%Op Inc 3Yr
16.92%Op Inc 5Yr
16.94%Net Inc 3Yr
16.01%Net Inc 5Yr

Returns

7.65%ROA
10.56%ROE
11.68%ROIC

Financial Health

¥111,750,000,000Cash & Cash Equivalents
¥79,533,000,000Net Debt
36.68%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Matsukiyococokara & Co. (ticker: 3088) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 12,753 employees. Market cap is $954.6B.

The current price is 2,337 with a P/E ratio of 17.46x and P/B of 1.83x.

ROE is 10.56% and operating margin is 7.73%. Annual revenue is $1.1T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Matsukiyococokara & Co. (3088) Stock Forecast 2026 ¥2,337 — Price, Financials & Analyst Targets | Alpha Lenz